Skip to main content
Loading

Innovating approaches to measure target engagement in the CNS

05 May 2026
Target Discovery
  • Innovating approaches to measure target engagement in the CNS:
  • Building discovery programs for a novel CNS target
  • Translational considerations for a first-in-class CNS therapeutic
  • Developing novel approaches for assessing CNS target engagement in clinical trials for a first-in-class drug
Industry Expert
Shane Hegarty, CSO - Axonis Therapeutics